Clinical Trials

Showing trials with last updates posted in 2024.

NCT02218099 | COMPLETED | PHASE1/PHASE2
55 participants

A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of ASP8232 in Subjects With Renal Impairment and in Type 2 Diabetes Mellitus Subjects With Chronic Kidney Disease

Study Type:
INTERVENTIONAL
Last Updated:
2024-10-31
Start Date:
2013-09-16
Completion:
2014-09-09
Conditions
  • Healthy Subjects
  • Pharmacokinetics of ASP8232
  • Pharmacodynamics of ASP8232
  • Chronic Kidney Disease (CKD)
  • Type 2 Diabetes Mellitus (T2DM)
Interventions
  • DRUG
No Results Yet
NCT02045862 | COMPLETED | PHASE3
1829 participants

A Multinational Study Comparing the Long-term Efficacy and Safety of Two Medicines, Solifenacin Succinate and Mirabegron Taken Together, or Separately, in Subjects With Symptoms of Overactive Bladder

Study Type:
INTERVENTIONAL
Last Updated:
2024-10-31
Start Date:
2014-03-17
Completion:
2016-09-08
Conditions
  • Urinary Bladder Overactive
  • Overactive Bladder
  • Urgency Incontinence
  • Urinary Bladder Diseases\Urologic Diseases
Interventions
  • DRUG
NCT01972841 | COMPLETED | PHASE3
3527 participants

This Was a Multinational Study Comparing the Efficacy and Safety of Two Medicines , Solifenacin Succinate and Mirabegron Taken Together, or Separately, or a Mock Treatment (Placebo) in Subjects With Symptoms of Overactive Bladder

Study Type:
INTERVENTIONAL
Last Updated:
2024-10-31
Start Date:
2013-11-05
Completion:
2015-10-22
Conditions
  • Urinary Bladder Overactive
  • Urinary Bladder Diseases\Urologic Diseases
  • Overactive Bladder
  • Urgency Incontinence
Interventions
  • DRUG
Previous
Sorted by latest updates
Next
Showing 40 trials per page